Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS
by
Mahida, Rahul Y.
, Perkins, Gavin D.
, Stewart, Paul M.
, Cooper, Mark C.
, Scott, Aaron
, Hardy, Rowan S.
, Lax, Siân
, Naidu, Babu
, Matthay, Michael A.
, Thickett, David R.
, Bassford, Christopher R.
, Parekh, Dhruv
in
11-beta-Hydroxysteroid Dehydrogenase Type 1 - genetics
/ 11-beta-Hydroxysteroid Dehydrogenase Type 1 - metabolism
/ 11b-hydroxysteroid dehydrogenase type-1
/ 11β-Hydroxysteroid dehydrogenase
/ Advanced glycosylation end products
/ alveolar macrophage (AM)
/ Alveoli
/ Animals
/ Anti-Inflammatory Agents
/ Apoptosis
/ ARDS (acute respiratory disease syndrome)
/ autocrine action
/ Autocrine signalling
/ Bronchoscopy
/ Clinical trials
/ Cortisol
/ Cortisone
/ Dehydrogenases
/ Glucocorticoids
/ Hormones
/ Hospitals
/ Hydrocortisone
/ Hydroxysteroid Dehydrogenases - metabolism
/ Immunology
/ Immunomodulation
/ Inflammation
/ Inflammatory diseases
/ Leukocytes (neutrophilic)
/ Lipopolysaccharides
/ Lungs
/ Macrophages
/ Macrophages, Alveolar - metabolism
/ Metabolism
/ Mice
/ Mortality
/ Ostomy
/ Patients
/ Peritonitis
/ Pneumonia
/ Proteins
/ Receptor for Advanced Glycation End Products
/ Recovery of function
/ Reductase
/ Respiratory Distress Syndrome
/ Sepsis
/ Sepsis - complications
/ Steroid hormones
/ Steroids
/ Thoracic surgery
/ Ventilators
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS
by
Mahida, Rahul Y.
, Perkins, Gavin D.
, Stewart, Paul M.
, Cooper, Mark C.
, Scott, Aaron
, Hardy, Rowan S.
, Lax, Siân
, Naidu, Babu
, Matthay, Michael A.
, Thickett, David R.
, Bassford, Christopher R.
, Parekh, Dhruv
in
11-beta-Hydroxysteroid Dehydrogenase Type 1 - genetics
/ 11-beta-Hydroxysteroid Dehydrogenase Type 1 - metabolism
/ 11b-hydroxysteroid dehydrogenase type-1
/ 11β-Hydroxysteroid dehydrogenase
/ Advanced glycosylation end products
/ alveolar macrophage (AM)
/ Alveoli
/ Animals
/ Anti-Inflammatory Agents
/ Apoptosis
/ ARDS (acute respiratory disease syndrome)
/ autocrine action
/ Autocrine signalling
/ Bronchoscopy
/ Clinical trials
/ Cortisol
/ Cortisone
/ Dehydrogenases
/ Glucocorticoids
/ Hormones
/ Hospitals
/ Hydrocortisone
/ Hydroxysteroid Dehydrogenases - metabolism
/ Immunology
/ Immunomodulation
/ Inflammation
/ Inflammatory diseases
/ Leukocytes (neutrophilic)
/ Lipopolysaccharides
/ Lungs
/ Macrophages
/ Macrophages, Alveolar - metabolism
/ Metabolism
/ Mice
/ Mortality
/ Ostomy
/ Patients
/ Peritonitis
/ Pneumonia
/ Proteins
/ Receptor for Advanced Glycation End Products
/ Recovery of function
/ Reductase
/ Respiratory Distress Syndrome
/ Sepsis
/ Sepsis - complications
/ Steroid hormones
/ Steroids
/ Thoracic surgery
/ Ventilators
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS
by
Mahida, Rahul Y.
, Perkins, Gavin D.
, Stewart, Paul M.
, Cooper, Mark C.
, Scott, Aaron
, Hardy, Rowan S.
, Lax, Siân
, Naidu, Babu
, Matthay, Michael A.
, Thickett, David R.
, Bassford, Christopher R.
, Parekh, Dhruv
in
11-beta-Hydroxysteroid Dehydrogenase Type 1 - genetics
/ 11-beta-Hydroxysteroid Dehydrogenase Type 1 - metabolism
/ 11b-hydroxysteroid dehydrogenase type-1
/ 11β-Hydroxysteroid dehydrogenase
/ Advanced glycosylation end products
/ alveolar macrophage (AM)
/ Alveoli
/ Animals
/ Anti-Inflammatory Agents
/ Apoptosis
/ ARDS (acute respiratory disease syndrome)
/ autocrine action
/ Autocrine signalling
/ Bronchoscopy
/ Clinical trials
/ Cortisol
/ Cortisone
/ Dehydrogenases
/ Glucocorticoids
/ Hormones
/ Hospitals
/ Hydrocortisone
/ Hydroxysteroid Dehydrogenases - metabolism
/ Immunology
/ Immunomodulation
/ Inflammation
/ Inflammatory diseases
/ Leukocytes (neutrophilic)
/ Lipopolysaccharides
/ Lungs
/ Macrophages
/ Macrophages, Alveolar - metabolism
/ Metabolism
/ Mice
/ Mortality
/ Ostomy
/ Patients
/ Peritonitis
/ Pneumonia
/ Proteins
/ Receptor for Advanced Glycation End Products
/ Recovery of function
/ Reductase
/ Respiratory Distress Syndrome
/ Sepsis
/ Sepsis - complications
/ Steroid hormones
/ Steroids
/ Thoracic surgery
/ Ventilators
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS
Journal Article
Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS
2023
Request Book From Autostore
and Choose the Collection Method
Overview
Acute Respiratory Distress Syndrome (ARDS) is a devastating pulmonary inflammatory disorder, commonly precipitated by sepsis. Glucocorticoids are immunomodulatory steroids that can suppress inflammation. Their anti-inflammatory properties within tissues are influenced by their pre-receptor metabolism and amplification from inactive precursors by 11β-hydroxysteroid dehydrogenase type-1 (HSD-1). We hypothesised that in sepsis-related ARDS, alveolar macrophage (AM) HSD-1 activity and glucocorticoid activation are impaired, and associated with greater inflammatory injury and worse outcomes.
We analysed broncho-alveolar lavage (BAL) and circulating glucocorticoid levels, AM HSD-1 reductase activity and Receptor for Advanced Glycation End-products (RAGE) levels in two cohorts of critically ill sepsis patients, with and without ARDS. AM HSD-1 reductase activity was also measured in lobectomy patients. We assessed inflammatory injury parameters in models of lung injury and sepsis in HSD-1 knockout (KO) and wild type (WT) mice.
No difference in serum and BAL cortisol: cortisone ratios are shown between sepsis patients with and without ARDS. Across all sepsis patients, there is no association between BAL cortisol: cortisone ratio and 30-day mortality. However, AM HSD-1 reductase activity is impaired in patients with sepsis-related ARDS, compared to sepsis patients without ARDS and lobectomy patients (0.075 v 0.882 v 0.967 pM/hr/10
AMs, p=0.004). Across all sepsis patients (with and without ARDS), impaired AM HSD-1 reductase activity is associated with defective efferocytosis (r=0.804, p=0.008) and increased 30-day mortality. AM HSD-1 reductase activity negatively correlates with BAL RAGE in sepsis patients with ARDS (r=-0.427, p=0.017). Following intra-tracheal lipopolysaccharide (IT-LPS) injury, HSD-1 KO mice demonstrate increased alveolar neutrophil infiltration, apoptotic neutrophil accumulation, alveolar protein permeability and BAL RAGE concentrations compared to WT mice. Caecal Ligation and Puncture (CLP) injury in HSD-1 KO mice results in greater peritoneal apoptotic neutrophil accumulation compared to WT mice.
AM HSD-1 reductase activity does not shape total BAL and serum cortisol: cortisone ratios, however impaired HSD-1 autocrine signalling renders AMs insensitive to the anti-inflammatory effects of local glucocorticoids. This contributes to the decreased efferocytosis, increased BAL RAGE concentrations and mortality seen in sepsis-related ARDS. Upregulation of alveolar HSD-1 activity could restore AM function and improve clinical outcomes in these patients.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
11-beta-Hydroxysteroid Dehydrogenase Type 1 - genetics
/ 11-beta-Hydroxysteroid Dehydrogenase Type 1 - metabolism
/ 11b-hydroxysteroid dehydrogenase type-1
/ 11β-Hydroxysteroid dehydrogenase
/ Advanced glycosylation end products
/ Alveoli
/ Animals
/ ARDS (acute respiratory disease syndrome)
/ Cortisol
/ Hormones
/ Hydroxysteroid Dehydrogenases - metabolism
/ Lungs
/ Macrophages, Alveolar - metabolism
/ Mice
/ Ostomy
/ Patients
/ Proteins
/ Receptor for Advanced Glycation End Products
/ Respiratory Distress Syndrome
/ Sepsis
/ Steroids
This website uses cookies to ensure you get the best experience on our website.